We found that higher expression (FRKM log2 value > 0.5) of LINC00857 was presented in bladder, gastric, lung AD, cervix and pancreas cancers, and lower in prostate, thyroid, brain, blood and skin cancers (FRKM log2 value < 0.5) (Supplementary Figure S6A). This evidence concerns the gene LINC00857 and pancreatic neoplasm.